Andrew K Balo is Director of GlucoTrack, Inc.. Currently has a direct ownership of 4,692 shares of GCTK, which is worth approximately $24,304. The most recent transaction as insider was on Oct 03, 2025, when has been sold 1,285 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.69K
37.72% 3M change
n/a 12M change
Total Value Held $24,304

Andrew K Balo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2025
BUY
Grant, award, or other acquisition
-
1,285 Added 21.5%
4,692 Common Stock, par valu...
Jul 11 2025
BUY
Grant, award, or other acquisition
-
3,332 Added 49.44%
3,407 Common Stock, par valu...
Mar 26 2025
BUY
Grant, award, or other acquisition
-
4,490 Added 50.0%
4,490 Common Stock, par valu...
Mar 25 2025
BUY
Grant, award, or other acquisition
-
75 Added 50.0%
75 Common Stock, par valu...

Also insider at

DXCM
DEXCOM INC Healthcare
AKB

Andrew K Balo

Director
San Diego, CA

Track Institutional and Insider Activities on GCTK

Follow GlucoTrack, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GCTK shares.

Notify only if

Insider Trading

Get notified when an Gluco Track, Inc. insider buys or sells GCTK shares.

Notify only if

News

Receive news related to GlucoTrack, Inc.

Track Activities on GCTK